The total return over the past 12 months is -16.77% vs. +16.94% for the S&P 500. So far it's up -2.25% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (16.77%) | (15.85%) | (28.41%) | +9.25% | +7.24% | +5.61% |
| Total Return CAGR | (16.77%) | (15.85%) | (28.41%) | +9.25% | +7.24% | +5.61% |
| Revenue CAGR | +51.30% | +3.53% | +10.49% | +15.57% | +12.41% | +9.88% |
| Net Income CAGR | N/A | (46.27%) | (28.65%) | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
STAAR Surgical Company (STAA)
| Year | Start price | End price | STAA Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $23.09 | $22.57 | (2.25%) | +14.51% | (16.76%) |
| 2025 | $24.29 | $23.09 | (4.94%) | +17.72% | (22.66%) |
| 2024 | $31.21 | $24.29 | (22.17%) | +24.89% | (47.06%) |
| 2023 | $48.54 | $31.21 | (35.70%) | +26.19% | (61.89%) |
| 2022 | $91.30 | $48.54 | (46.83%) | (18.17%) | (28.66%) |
| 2021 | $79.22 | $91.30 | +15.25% | +28.74% | (13.49%) |
| 2020 | $35.17 | $79.22 | +125.25% | +18.37% | +106.88% |
| 2019 | $31.91 | $35.17 | +10.22% | +31.22% | (21.00%) |
| 2018 | $15.50 | $31.91 | +105.87% | (4.56%) | +110.43% |
| 2017 | $10.85 | $15.50 | +42.86% | +21.70% | +21.16% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
